[Correspondence] Correspondence to editorial on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: A real-world study”
Clin. Mol. Hepatol., Volume 30(4); Oct 2024 | https://doi.org/10.3350/cmh.2024.0394
A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Am. J. Gastroenterol., 2023 Feb 3 | doi: 10.14309/ajg.0000000000002185